中文 | English
Return
Total: 25 , 1/3
Show Home Prev Next End page: GO
Author:(Xuegong FAN)

1.Studies on relationship between resistance to vancomycin and the coagulase activity of S.aureus

Hong DAI ; Xuegong FAN

Chinese Journal of Clinical Laboratory Science 2006;0(01):-

2.Studies on relationship between resistance to vancomycin and changes of coagulase gene sequences of S.aureus

Hong DAI ; Xuegong FAN

Chinese Journal of Clinical Laboratory Science 2006;0(02):-

3.Clinical significance of serum Slit2 protein in patients with chronic severe hepatitis B

Ning LI ; Xuegong FAN

Chinese Journal of Infection Control 2015;(11):726-729

4.Progress of Bioinformatics Study in DNA Methylation

Shicai FAN ; Xuegong ZHANG

Progress in Biochemistry and Biophysics 2006;0(02):-

5.Preliminary Studies on Hepatic Tissue Proteome of HBV Relative Hepatocellular Carcinoma by Two-Dimensional Gel Electrophoresis

Yunzhu LONG ; Xuegong FAN ; Ning LI

Journal of Chinese Physician 2001;0(06):-

6.The role of FASL and TRAIL in the AICD of PBLs in patients with chronic hepatitis B

Zhengbo LIU ; Guoling HU ; Xuegong FAN

Chinese Journal of Immunology 1985;0(02):-

7.Clinical application of intraoperative epicardial echocardiography in cardiac valve surgery

Ruixia TIAN ; Xuegong SHI ; Xun CHEN ; Leilei FAN ; Chaolong JIN

Chinese Journal of Ultrasonography 2012;(7):581-582

8.The influence of HCV core protein on cell apoptosis,cell cycles and cell telomerase activities of HepG2 cells

Jun QUAN ; Guoling HU ; Xuegong FAN ; Al ET ;

Chinese Journal of Infectious Diseases 2001;0(03):-

9.Characteristic of Drug Resistance in Staphylococcus aureus

Mingxiang ZOU ; Xuegong FAN ; Gan LI ; Wenen LIU ; Xian LI

Chinese Journal of Nosocomiology 2006;0(05):-

10.Preliminary study on human immune cells activated by CpG-ODN

Ning LI ; Xuegong FAN ; Lizhang CHEN ; Zhaohui CHEN ; Hongbo LIU

Chinese Journal of Immunology 1985;0(06):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 25 , 1/3 Show Home Prev Next End page: GO